These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12270558)

  • 1. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium.
    Kuczyński J; Uszyński W; Zekanowska E; Soszka T; Uszyński M
    Eur J Obstet Gynecol Reprod Biol; 2002 Oct; 105(1):15-9. PubMed ID: 12270558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J
    Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):163-6. PubMed ID: 11301162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.
    Takahashi H; Sato N; Shibata A
    Thromb Res; 1995 Nov; 80(4):339-48. PubMed ID: 8585047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.
    Teng Y; Jiang R; Lin Q; Ding C; Ye Z
    Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-selectin in placenta and gestational myometrium: its measurements and hypothetical role in hemostasis of placental bed after labor.
    Uszyński M; Uszyński W; Zekanowska E
    J Perinat Med; 2008; 36(3):213-6. PubMed ID: 18576930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.
    Erez O; Espinoza J; Chaiworapongsa T; Gotsch F; Kusanovic JP; Than NG; Mazaki-Tovi S; Vaisbuch E; Papp Z; Yoon BH; Han YM; Hoppensteadt D; Fareed J; Hassan SS; Romero R
    J Matern Fetal Neonatal Med; 2008 Oct; 21(10):732-44. PubMed ID: 19012190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentration of annexin V in gestational tissues: placenta, fetal membranes, myometrium and amniotic fluid].
    Uszyński W; Zekanowska E; Uszyński M; Rystok D
    Ginekol Pol; 2006 Aug; 77(8):603-9. PubMed ID: 17076191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
    Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
    J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor, its pathway inhibitor, and metabolic disturbances in long-term peritoneal dialysis.
    Zemanová P; Opatrný K; Opatrná S; Vít L; Sefrna F; Racek J
    Kidney Blood Press Res; 2003; 26(5-6):368-75. PubMed ID: 14610342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of tissue factor and its inhibitor in chronic thromboembolic pulmonary hypertension: a step closer to explanation of the disease aetiology?
    Cisowska-Czajka ME; Mazij MP; Kotschy MH; Lewczuk J
    Kardiol Pol; 2016; 74(11):1332-1338. PubMed ID: 27221958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls.
    Blann AD; Amiral J; McCollum CN; Lip GY
    Atherosclerosis; 2000 Sep; 152(1):29-34. PubMed ID: 10996336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
    Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
    Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation.
    Yamamuro M; Wada H; Kumeda K; Inoue A; Tsuji I; Nakasaki T; Shimura M; Hiyoyama K; Gabazza EC; Nishikawa M; Deguchi K; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):491-7. PubMed ID: 9818999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary estimation of tissue factor pathway inhibitor (TFPI) and protein C in patients with intracranial tumors.
    Rość D; Grabarczyk E; Bierwagen M; Wierciński M; Góralczyk K; Haor B; Ruszkowska-Ciastek B
    Adv Clin Exp Med; 2017 Nov; 26(8):1219-1224. PubMed ID: 29264878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of tissue factor and tissue factor pathway inhibitor in neonatal jaundice due to infection].
    Yue SJ; Zhong L; He XF; Yang YJ; Jiang L; He SL; Li JC
    Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):104-6. PubMed ID: 14759309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.